Hodgkin's disease	is a	cancer
Hodgkin's disease	is a	lymphoma
Hodgkin's disease	is a	hematologic malignancy
Hodgkin's disease	presents with	painless lymphadenopathy
Hodgkin's disease	presents with	fever
Hodgkin's disease	presents with	night sweats
Hodgkin's disease	presents with	weight loss
Hodgkin's disease	has	bimodal age distribution
Hodgkin's disease	associated with	EBV infection
Hodgkin's disease	diagnosed by	lymph node biopsy
Lymph node biopsy	reveals	Reed-Sternberg cells
Reed-Sternberg cells	indicate	Hodgkin's disease
Hodgkin's disease	staged by	Ann Arbor staging system
Hodgkin's disease	classified into	nodular sclerosis
Hodgkin's disease	classified into	mixed cellularity
Hodgkin's disease	classified into	lymphocyte-rich
Hodgkin's disease	classified into	lymphocyte-depleted
Hodgkin's disease	treated with	ABVD regimen
ABVD regimen	contains	doxorubicin
ABVD regimen	contains	bleomycin
ABVD regimen	contains	vinblastine
ABVD regimen	contains	dacarbazine
Doxorubicin	causes	cardiotoxicity
Bleomycin	causes	pulmonary toxicity
Vinblastine	causes	neuropathy
Dacarbazine	causes	myelosuppression
Hodgkin's disease	treated with	chemotherapy
Hodgkin's disease	treated with	radiotherapy
Stage I Hodgkin's disease	treated with	radiotherapy
Stage II Hodgkin's disease	treated with	radiotherapy
Stage III Hodgkin's disease	treated with	combined modality therapy
Stage IV Hodgkin's disease	treated with	systemic therapy
Systemic therapy	includes	chemotherapy
Radiation therapy	can cause	secondary malignancy
Mediastinal mass	seen in	Hodgkin's disease
PET-CT	used for	staging
PET-CT	used for	response assessment
Ann Arbor staging system	defines	stage Iâ€“IV
B symptoms	include	fever
B symptoms	include	night sweats
B symptoms	include	weight loss
Early stage Hodgkin's disease	prognosis	favorable
Advanced stage Hodgkin's disease	prognosis	poorer
Hodgkin's disease	more common in	males
Hodgkin's disease	more common in	young adults
Hodgkin's disease treatment	associated with	infertility
Fertility preservation	recommended before	chemotherapy
EBV infection	associated with	Hodgkin's disease
BEACOPP regimen	is used for	advanced Hodgkin's disease
BEACOPP regimen	more intensive than	ABVD
BEACOPP regimen	includes	etoposide
BEACOPP regimen	includes	cyclophosphamide
BEACOPP regimen	includes	doxorubicin
BEACOPP regimen	includes	vincristine
BEACOPP regimen	includes	procarbazine
BEACOPP regimen	includes	prednisone
Radiation therapy	provides	locoregional control
Radiation therapy	long-term toxicity	hypothyroidism
Relapse	occurs after	remission
Remission	achieved with	chemotherapy
Remission	achieved with	radiotherapy
PET-CT response	predicts	survival
Metabolic response	predicts	prognosis
Pulmonary function	affected by	bleomycin
Cardiac function	affected by	doxorubicin
Hodgkin's disease	recurrence risk	after treatment
Hodgkin's disease survivors	require	long-term follow-up
Long-term follow-up	includes	imaging surveillance
Second malignancy	risk after	Hodgkin's disease therapy
Fertility	impacted by	Hodgkin's disease treatment
Fertility preservation	reduces	infertility risk
Pediatric Hodgkin's disease	distinct from	adult Hodgkin's disease
Prognostic factors	include	stage
Prognostic factors	include	B symptoms
Prognostic factors	include	bulky disease
Bulky disease	defined as	lymph node mass >10 cm
Cure rate	high in	early stage Hodgkin's disease
Cure rate	high in	pediatric Hodgkin's disease
Non-relapse survival	improved by	early therapy
Vaccination status	important for	Hodgkin's disease patients under therapy
Clinical trials	options for	relapsed Hodgkin's disease
Relapsed Hodgkin's disease	treated with	salvage chemotherapy
Salvage chemotherapy	includes	high-dose regimens
Autologous stem cell transplant	used for	relapsed Hodgkin's disease
Stem cell transplant	offers	durable remission
Hodgkin's disease	monitored with	complete blood count
Eosinophilia	observed in	Hodgkin's disease
CD30 antigen	expressed in	Reed-Sternberg cells
CD15 antigen	expressed in	Reed-Sternberg cells
CD20 antigen	not expressed in	classical Hodgkin's disease
Classical Hodgkin's disease	immunophenotype	CD30-positive
Reed-Sternberg cells	test positive for	CD30
Reed-Sternberg cells	test positive for	CD15
CD15	marker for	Reed-Sternberg cells
Familial predisposition	increases risk for	Hodgkin's disease
Mediastinal involvement	common in	nodular sclerosis Hodgkin's disease
Painless lymphadenopathy	hallmark of	Hodgkin's disease
Prognosis	improves with	early detection
Chemotherapy	reduces tumor burden	Hodgkin's disease
Tumor burden	correlates with	prognosis
